| Class / Patent application number | Description | Number of patent applications / Date published |
|---|
| 536280600 | N-glycosides wherein the N is part of a five-membered hetero ring (e.g., selenazole nucleosides, pyrrole nucleosides, etc.) | 9 |
| 20140206858 | PROCESS FOR THE PREPARATION OF COMPOUNDS USEFUL AS INHIBITORS OF SGLT-2 - The present invention is directed to a novel process for the preparation of compounds having inhibitory activity against sodium-dependent glucose transporter (SGLT) being present in the intestine or kidney. | 07-24-2014 |
| 20140206859 | PROCESS FOR THE PREPARATION OF COMPOUNDS USEFUL AS INHIBITORS OF SGLT-2 - The present invention is directed to a novel process for the preparation of compounds having inhibitory activity against sodium-dependent glucose transporter (SGLT) being present in the intestine or kidney. | 07-24-2014 |
| 536280700 | Plural nitrogens in the N-hetero ring (e.g., triazoles, etc.) | 7 |
| 20130116422 | DENDRITIC STARCH-BASED DEXTRIN ADHESIVES - Starch-based dextrin adhesive additives and methods of preparation are described. Adhesives containing the additive exhibit antimicrobial properties and increased water solubility. The additive contains at least one sugar unit, at least one polyphenol side chain, and at least one Frechet-type poly(aryl ether)dendron. | 05-09-2013 |
| 20140288295 | OLIGOMER CONJUGATES OF HETEROPENTACYCLIC NUCLEOSIDES - The invention provides small molecule drugs that are chemically modified by covalent attachment of a water-soluble oligomer. | 09-25-2014 |
| 536280800 | The N-hetero ring is a 1,3-diazole ring, including hydrogenated (e.g., imidazoles, etc.) | 5 |
| 20120178920 | METHOD FOR PREPARING [18F]FALLYPRIDE WITH LOW BASE CONCENTRATION - A method for preparing [ | 07-12-2012 |
| 20130211066 | COMPOUNDS USEFUL IN IMAGING AND THERAPY - Provided in the following specification are precursors or synthons that are useful for the synthesis of various arabinose based chemical and radiochemical derivatives of nitroimidazole-containing azomycin arabinosides, such as radioiodinated 1-#-D-(5-deoxy-5-[I*]-iodoarabinofuranosyl)-2-nitroimidazole (*IAZA), and radiofluorinated 1-#-D-(5-deoxy-5-[18F]-iodoarabinofuranosyl)-2-nitroimidazole (18FAZA). Such compounds are useful in imaging, therapy, or radiotherapy. Further, various syntheses of said precursors/synthons and the incorporation of said precursors/synthons into kits is provided. The precursors/synthons provided herein allow for an improved and facile manufacturing process for nitroimidazole-containing azomycin arabinosides. | 08-15-2013 |
| 20180021750 | Disconnector Device | 01-25-2018 |
| 536280900 | Benzimidazoles | 2 |
| 20090187015 | Process For Preparing Substituted Benzimidazole Compounds - The invention relates to new methods of preparing substituted benzimidazole compounds, such as 2-bromo-5,6-dichlorobenzimidazole, which are useful in the preparation of compounds having antiviral activity. | 07-23-2009 |
| 20130296542 | CRYSTALLINE PHASES OF 5,6-DICHLORO-2-(ISOPROPYLAMINO)-(1- -L-RIBOFURANOSYL)-1H-BENZIMIDAZOLE - The invention relates to novel crystalline phases of 5,6-dichloro-2-(isopropylamino)-1-(β-L-ribofuranosyl)-1H-benzimidazole (Maribavir), pharmaceutical compositions thereof and their use in medical therapy. | 11-07-2013 |
